Blackrock Health Sciences Trust closed at $44.63 on Sep 28, down 0.47%, 3.6% below its 52-week closing high. Volume of 43.7K shares was 1.17× its 20-day average (close to normal).
Split-adjusted performance: -3.2% over one month, +18.5% over six months, +23.8% over one year.
Short interest was 33.8K shares at the Sep 15 settlement, down 19.5% from the prior report (0.3% of float, 1.0 days to cover).
No recent articles focused on Blackrock Health Sciences Trust.
Quick answers
What does Blackrock Health Sciences Trust do?
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
What is BME's market cap?
$576.80M, based on the Sep 28 close of $44.63.
Does Blackrock Health Sciences Trust pay a dividend?
Yes. The latest regular dividend was $0.2621 per share (ex-date Sep 15), an annualised yield of 7.05%.
How much of BME is sold short?
33.8K shares, 0.3% of float, as of Sep 15, 2026.
About Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
